A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension
about
Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focusAdvantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol CombinationPredictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combinationConsiderations in glaucoma therapy: fixed combinations versus their component medications.Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study.Efficacy and safety of switching to latanoprost 0.005%-timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 monthsComparative efficacy and safety of the fixed versus unfixed combination of latanoprost and timolol in Chinese patients with open-angle glaucoma or ocular hypertension.Clinical options for the reduction of elevated intraocular pressureComparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial.Fixed combination of latanoprost and timolol vs the individual components for primary open angle glaucoma and ocular hypertension: a systematic review and meta-analysisShort term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies.An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension.Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination.Diurnal intraocular pressure with bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in healthy subjects.Comparison of latanoprost/timolol with carbonic anhydrase inhibitor and dorzolamide/timolol with prostaglandin analog in the treatment of glaucoma.Role of fixed combinations in the management of open-angle glaucoma.Intraocular pressure-lowering combination therapies with prostaglandin analogues.Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature.Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study.24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol.Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.The 24-hour intraocular pressure control by tafluprost/timolol fixed combination after switching from the concomitant use of tafluprost and timolol gel-forming solution, in patients with primary open-angle glaucoma.
P2860
Q26830201-D63E369B-4604-42F9-B6FF-66168326C861Q28552385-537BA5FC-1707-4373-BB67-B59CBD5711B9Q33546682-5A8D2A6E-4423-45BF-A10D-933EC5FB6E73Q33644139-F88DA234-43D4-4F54-BC5D-E4044BD06F12Q33687798-A727D04B-BBBF-40E7-8CEB-2B7E64628D06Q33863765-789430D2-6429-42D8-962A-F9021DD2B0EBQ33996251-A35B127F-EB61-4496-AC49-2333368A6088Q34708267-3855FAF6-B8A6-4340-A0D6-D522D778611CQ35060425-30F227C7-5BD2-46B9-A23C-12C565FB6B82Q35370679-CB5DC50E-CAEA-4B1D-85E0-9A180FF228DCQ35592524-E68A30B5-F47C-4050-B5DE-EA725D54F01BQ35753429-FCF781F5-13D6-4EEA-BAAA-77928CEE10E8Q35922145-6AAAD25A-EAC4-4A83-AD3E-B55A207E9BE7Q37555451-73890C9F-ED06-48CE-998E-2D2F1E94343BQ37661382-41140D40-EC22-4EC4-B196-D01A6C3F8452Q37847155-30762B96-0139-49E7-A4F3-DBB671DD1D69Q38017728-AEF3A5C4-6F5E-441B-B498-7A8915726D36Q42029736-1E3ECB5D-3345-437E-9B0F-74778BA64D64Q45929500-87FD6A3B-3CBD-42CE-8D40-DC039F8FD4C3Q46032736-42536EC7-83A8-44A0-B673-13F3F5BE840BQ46739178-ED4E167A-B60D-4391-BEB2-53C14AE30750Q55362967-9A889AEC-C095-47FD-B07D-67A5AB1B06E7
P2860
A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A 12 week study comparing the ...... aucoma and ocular hypertension
@ast
A 12 week study comparing the ...... aucoma and ocular hypertension
@en
type
label
A 12 week study comparing the ...... aucoma and ocular hypertension
@ast
A 12 week study comparing the ...... aucoma and ocular hypertension
@en
prefLabel
A 12 week study comparing the ...... aucoma and ocular hypertension
@ast
A 12 week study comparing the ...... aucoma and ocular hypertension
@en
P2093
P2860
P356
P1476
A 12 week study comparing the ...... aucoma and ocular hypertension
@en
P2093
European Latanoprost Fixed Combination Study Group
L-I Larsson
M Diestelhorst
P2860
P304
P356
10.1136/BJO.2003.018234
P407
P577
2004-02-01T00:00:00Z